|
Showing the most relevant articles for your search:NYSE:ELN | Date | Time | Source | Headline | Symbol | Company | | 06/28/2013 | 4:46PM | Edgar (US Regulatory) | Amended Annual and Transition Report (foreign Private Issuer) (20-f/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/28/2013 | 10:15AM | PR Newswire (US) | Magnetar Financial LLC - Form 8.3 - Elan Corporation Plc | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 5:29PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 5:23PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 5:09PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 4:49PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 6:43AM | PR Newswire (US) | Royalty Pharma Announces Withdrawal Of Judicial Review And Lapse Of Offer | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 2:00AM | Business Wire | Elan Advises Shareholders to Withdraw Any Acceptances of the Royalty Pharma Offer & Not to Tender Any Further Acceptances int... | NYSE:ELN | Elan Corp., Plc Adr |
| 06/18/2013 | 2:00AM | Business Wire | Elan Advises Shareholders to Withdraw Any Acceptances of the Royalty Pharma Offer & Not to Tender Any Further Acceptances int... | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 5:15PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 5:11PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 4:55PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 10:31AM | PR Newswire (US) | Royalty Pharma Informs Elan Stockholders About The Consequences Arising From The Results Of The Elan EGM Earlier Today | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 9:20AM | Dow Jones News | Royalty Pharma's Offer for Elan Lapses | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 6:25AM | Business Wire | Elan Announces Results of EGM | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 6:25AM | Business Wire | Elan Announces Results of EGM | NYSE:ELN | Elan Corp., Plc Adr |
| 06/17/2013 | 2:26AM | PR Newswire (US) | Royalty Pharma Chairman Writes Open Letter to Elan Board | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 5:14PM | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 5:13PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 5:13PM | Edgar (US Regulatory) | Mutual Fund Summary Prospectus (497k) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 5:08PM | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (sc 14d9/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 1:34PM | PR Newswire (US) | Royalty Pharma Notes Elan Sales Process Offers Shareholders No Certainty | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 1:00PM | Dow Jones News | Elan Puts Itself Up for Sale | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 12:18PM | Dow Jones News | EUROPE MARKETS: European Stocks Drop For Fourth Straight Week | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 9:16AM | Business Wire | Elan To Proceed with Formal Sale Process | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 9:16AM | Business Wire | Elan To Proceed with Formal Sale Process | NYSE:ELN | Elan Corp., Plc Adr |
| 06/14/2013 | 1:41AM | PR Newswire (US) | Elan ADS Holders Decisively Vote Against Theravance And AOP Transactions | NYSE:ELN | Elan Corp., Plc Adr |
| 06/13/2013 | 5:27PM | Edgar (US Regulatory) | Explanation of Responses: (144) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/13/2013 | 5:18PM | Edgar (US Regulatory) | Amended Tender Offer Statement by Third Party (sc To-t/a) | NYSE:ELN | Elan Corp., Plc Adr |
| 06/13/2013 | 1:00PM | Zacks | PDL BioPharma Guides Higher 2Q Royalties - Analyst Blog | NYSE:ELN | Elan Corp., Plc Adr |
|
Showing the most relevant articles for your search:NYSE:ELN |
|